3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience

Michele Caruso,Gaetano Castiglione,Rosanna Aiello,M. Ali,Maurizio Chiarenza,Rosanna Dimarco,Giuseppa Fallica,Maria Grazia Di Leo,Maria Vita Sanò,Eleonora Taibi,Alessandra Zacchia,Eleonora Miano,Francesco Caruso

3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience

2015

Michele Caruso
Gaetano Castiglione
Rosanna Aiello
M. Ali
Maurizio Chiarenza
Rosanna Dimarco
Giuseppa Fallica
Maria Grazia Di Leo
Maria Vita Sanò
Eleonora Taibi
Alessandra Zacchia
Eleonora Miano
Francesco Caruso

Medical Oncology, Humanitas Catania Oncology Center, Catania, Italy Surgical Oncology, Humanitas Catania Oncology Center, Catania, Italy Statistical & Data Management Unit, Humanitas Catania Oncology Center, Catania, Italy *Author for correspondence: Tel.: +39 095 7339 0108; michele.caruso@ccocatania.it

Keywords:

Breast cancer
Hormone receptor
Gonadotropin-releasing hormone
Triptorelin
Gynecology
Humanitas
Surgical oncology
Medicine
Pathology
General surgery
early breast cancer
neoplasm staging
treatment outcome

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations